Taiwan FDA registration b9f69eaca62818aaeb7466a080d6e4e2

"Quirk" superior blood glucose monitoring system

TW: "艾奎克" 卓越血糖監測系統

Taiwan·Risk Class 2·Shengyao Technology Co., Ltd. forest factory·Registered Apr 14, 2021 – Apr 14, 2026Expired

Registration details

Analysis ID: b9f69eaca62818aaeb7466a080d6e4e2

Company information

Manufacturer: Shengyao Technology Co., Ltd. forest factory
Manufacturer Country: Taiwan, Province of China
Authorized Representative: Shengyao Technology Co., Ltd. forest factory

Product details

Intended Use: The efficacy has been changed to: This product is used for in vitro diagnostic quantitative detection of blood glucose in microvascular whole blood (fingertip) or venous blood samples. This product is suitable for diabetic patients at home and professional use.
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A.1345 Glucose Test System
Import Information: 國產;; QMS/QSD

Dates and status

Registration Date: Apr 14, 2021
Expiry Date: Apr 14, 2026

About this record

Access comprehensive regulatory information for "Quirk" superior blood glucose monitoring system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number b9f69eaca62818aaeb7466a080d6e4e2 and manufactured by Shengyao Technology Co., Ltd. forest factory. The authorized representative in Taiwan is Shengyao Technology Co., Ltd. forest factory.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.